A new study has found that transvaginal mesh complications are more likely to occur in younger women, or those with less prominent prolapse. The study specifically involved women who received the surgical mesh device to treat pelvic organ prolapse (POP).
The study involved 677 women who had surgery to implant a transvaginal mesh device. More than 17% of the women suffered from serious vaginal mesh complications, including internal bleeding, vaginal hematoma, bladder damage and rectal damage.
Several transvaginal mesh manufacturers have recalled their devices, including Johnson & Johnson and C.R. Bard. These companies could face thousands of transvaginal mesh lawsuits alleging that the devices were defective and led to severe side effects, including limited mobility, tissue damage and vaginal organ perforation.